Sugi Predict

Sugi Predict / Compounds / SCHEMBL7330179

SCHEMBL7330179

SCHEMBL7330179

O=C(OCc1ccccc1)C1SCCCS1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.59
▸ TSHR P16473 1/20 0.48
▸ FABP7 O15540 1/20 0.48
▸ FABP5 Q01469 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.47
▸ PREP P48147 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ FKBP1A P62942 3/20 0.43
▸ LMNA P02545 1/20 0.42
▸ HCAR2 Q8TDS4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8534632 0.93 ALDH1A1 (0.50) FAAHTSHRFABP7FABP5ALDH1A1
SCHEMBL17766262 0.75 TSHR (0.55) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL2703515 0.75 FABP7 (0.55) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL16347238 0.75 TSHR (0.55) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL3664444 0.75 TSHR (0.58) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL7757006 0.74 FABP7 (0.73) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL6666657 0.74 FABP7 (0.58) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL12114007 0.74 FABP7 (0.73) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL7757018 0.74 FABP7 (0.73) TSHRFABP7FABP5ALDH1A1MAPK1
SCHEMBL10917021 0.74 FABP7 (0.58) TSHRFABP7FABP5ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9758688-B2 Composition for forming conductive film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 — — US disclosed
US-9309276-B2 Synthetic lipid A derivative UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2016-04-12 — — US disclosed
US-20150275015-A1 COMPOSITION FOR FORMING CONDUCTIVE FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-01 — — US disclosed
US-20140011987-A1 Synthetic Lipid A Derivative UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2014-01-09 — — US disclosed
US-8563523-B2 Synthetic lipid A derivative UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2013-10-22 — — US disclosed
US-20110280893-A9 SYNTHETIC LIPID A DERIVATIVE UNIVERSITY OF GEORGIA RESEACH FOUNDATION, INC (US) 2011-11-17 — — US disclosed
US-20100221269-A1 SYNTHETIC LIPID A DERIVATIVE UNIVERSITY OF GEORGIA RESEACH FOUNDATION, INC (US) 2010-09-02 — — US disclosed
EP-0504612-B1 Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them AMERICAN CYANAMID CO (US) 1998-01-21 — — EP disclosed
US-5700930-A 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them AMERICAN CYANAMID COMPANY (US) 1997-12-23 — — US disclosed
US-5656753-A 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them AMERICAN CYANAMID COMPANY (US) 1997-08-12 — — US disclosed
US-4661479-A ENZYME INHIBITORS MERCK AND CO., INC. (US) 1987-04-28 — — US disclosed
US-4629787-A ANGIOTENSIN CONVERTING ENZYME INHIBITORS MERCK & CO., INC. (US) 1986-12-16 — — US disclosed
EP-0061187-B1 BICYCLIC LACTAMS AS ANTIHYPERTENSIVES MERCK & CO. INC. (US) 1986-08-20 — — EP disclosed
EP-0046291-B1 SUBSTITUTED CAPROLACTAM DERIVATIVES AS ANTIHYPERTENSIVES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND INTERMEDIATES MERCK & CO. INC. (US) 1985-12-27 — — EP disclosed
US-4472380-A CARBOXYALKYL DIPEPTIDE DERIVATIVES MERCK & CO., INC. (US) 1984-09-18 — — US disclosed
US-4415496-A HYPOTENSIVE AGENTS; 5-OXOTHIAZOLO/3,2-A/AZEPINE DERIVATIVES FROM A PHTHALIMIDE MERCK & CO., INC. (US) 1983-11-15 — — US disclosed
US-4374829-A Aminoacid derivatives as antihypertensives MERCK & CO., INC. (US) 1983-02-22 — — US disclosed
EP-0061187-A1 Bicyclic lactams as antihypertensives MERCK & CO. INC. (US) 1982-09-29 — — EP disclosed
EP-0046291-A2 Substituted caprolactam derivatives as antihypertensives, process for preparing them, pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 — — EP disclosed
EP-0012401-A1 Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them MERCK & CO. INC. (US) 1980-06-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140011987-A1 Synthetic Lipid A Derivative DDOST, STT3A, UGCG FAAH 560/4885TSHR 1943/4885FABP7 290/4885
US-20110280893-A9 SYNTHETIC LIPID A DERIVATIVE DDOST, STT3A, UGCG FAAH 560/4885TSHR 1943/4885FABP7 290/4885
US-20100221269-A1 SYNTHETIC LIPID A DERIVATIVE DDOST, STT3A, UGCG FAAH 560/4885TSHR 1943/4885FABP7 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.